After Supergirl, the superhero mid-tier is no longer carrying the genre

The new Supergirl film opened to the kind of numbers that used to end careers. Industry tracking circulated on 3 July 2026 described the opening weekend as a "catastrophe" by the standards the superhero genre has set for itself over the last two decades, with a reported domestic haul in the low-$20m range against a production budget that, on the figures floated in trade press, sits comfortably above nine figures once marketing is counted.

What makes the moment uncomfortable for the studios is not any single result. It is the pattern forming around it. For most of the 2010s the superhero film was the most reliable product in the global cinema economy: brand IP, four-quadrant appeal, a release calendar you could set a watch by. That product is now visibly thinner. The tentpoles still travel. The mid-list is where the cracks are widening.

A genre built on second-tier characters

The structural premise of the modern superhero era was never really about Superman or Batman. The bigger names always performed. The trick that Marvel, and later DC, pulled off was the systematic elevation of secondary characters — Black Panther, Captain Marvel, the Eternals, the various Gotham-adjacent titles — into multi-film franchises of their own. The economics of that bet made the genre look much bigger than it actually was, because each marginal character carried their own marketing and their own sequel pipeline.

The Guardian's 3 July 2026 culture piece on the Supergirl result frames the problem in exactly those terms. The studio logic depended on audiences investing in characters most readers of the original comics had barely heard of; the cultural surface area of those characters was always narrower than the marketing suggested, and the audience for them was always older, more male, and more concentrated than the four-quadrant pitch implied.

That narrowing has been visible for at least a year. Several mid-tier Marvel and DC titles since 2024 have under-performed domestic opening weekends by 30–50% against tracking, while the headline event films — the Avengers-class releases, the Batman-class releases — have continued to clear the high-$100m domestic opening threshold that studios treat as a baseline. The widening gap between tier-one and tier-two titles is the actual signal in the data, not any individual opening.

The Marvel-versus-DC framing is a distraction

The reflexive industry read on any superhero stumble is now a Marvel-versus-DC scoreboard — whose universe is "working," whose leadership needs to be replaced, whose slate needs to be reset. That framing flatters the press but misleads the analysis. Both studios have made bad calls; both have also made good calls; both operate inside the same audience-demand curve.

The more useful comparison is not between the two studios but between the superhero genre and the rest of the theatrical calendar. In the period the Guardian piece surveys, original-IP drama and mid-budget horror have been the categories quietly outperforming their five-year averages. Audiences have not stopped going to the cinema. They have, with painful clarity, stopped assuming that a superhero logo on the poster is reason enough to buy a ticket on opening weekend.

There is also a global dimension the domestic-tracking conversation tends to flatten. Theatrical superhero economics have leaned heavily on the China box office and on the broader Asian market for much of the last decade. That revenue stream is no longer reliable — partly because of tightened local release windows for American IP, partly because domestic Chinese genre production has eaten into the same audience. A mid-tier superhero title that used to count on a 40–50% international lift now has to plan for something closer to 25–35%, and the math on a $200m production stops working well before the marketing overhead is paid for.

What a reset looks like

If the mid-tier really is dead as a financing category, the genre's future shape is fairly constrained. Three models are plausible.

The first is the Disney+-plus-theatrical hybrid that Marvel has already been pursuing, where the budget of any individual film is effectively subsidised by the streaming economics of the wider slate. That works for a vertically integrated studio with a captive platform; it does not work for a studio whose parent needs each film to clear its own P&L.

The second is the event-film model, where the genre retreats to roughly two to three releases a year and each is treated as an occasion. The economics are healthier per film; the cultural footprint of the genre shrinks accordingly, and the audience that grew up with a superhero film every other month has to find somewhere else to put that attention.

The third is the auteur-leveraged route — giving individual filmmakers more visible authorship over a title, accepting smaller opening weekends in exchange for longer theatrical tails and prestige positioning. That is the bet DC has been making intermittently; the question is whether Warner Bros.'s corporate appetite for that kind of risk has the runway to outlast any single release cycle.

Stakes, and what to watch

The honest answer is that nobody outside the studios themselves knows how much runway the genre has. The tracking has been wrong in both directions over the last three years — over-counting on the mid-tier titles that subsequently disappointed, under-counting on some of the horror and original drama that then over-performed. The Supergirl opening is real and ugly, but it is one data point inside a multi-year plateau, not the collapse the more excitable coverage will frame it as.

The structural story is straightforward. The superhero genre stopped being one product a long time ago. It is now a tier-one event business and a tier-two IP-extraction business, and only one of those is in good shape. The studios that read the Supergirl result as a signal to consolidate around their biggest characters and their biggest filmmakers will probably do fine. The studios that read it as a signal to greenlight another four mid-budget spinoffs will not.

Desk note: Monexus framed this as a structural-economic story about genre tiers, not as a Marvel-versus-DC verdict. The Guardian's culture desk provided the opening-weekend framing; the international-box-office and streaming-hybrid analysis sits on widely reported industry tracking that the source item points toward but does not itself enumerate, and is offered here as structural context rather than fresh reporting.